Experimental cancer drug ART0380 trial halted early
Disease control
Terminated
This study tested an experimental drug called ART0380 in 36 people with advanced or metastatic solid tumors, including endometrial cancer. The drug was taken by mouth and aimed to shrink tumors by blocking a protein involved in cancer cell growth. The trial was terminated early, …
Phase: PHASE2 • Sponsor: Artios Pharma Ltd • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC